Related Experiment Video
Updated: Jun 2, 2026
06:40
Cost-Efficient Transcriptomic-Based Drug Screening
Published on: February 23, 2024
One foundation's strategy to accelerate drug discovery through genomics
Louise M Perkins1, Anne Quinn Young, Kathy Giusti
1Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium, Norwalk, CT 06851, USA.
Science Translational Medicine
|April 15, 2011
Summary
The Multiple Myeloma Research Foundation (MMRF) accelerates new drug development for multiple myeloma by investing in genomics and epigenetics research. This approach aims to personalize treatments by understanding the disease
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Multiple myeloma is a cancer of plasma cells.
- Developing effective treatments remains a challenge.
Purpose of the Study:
- To accelerate the development of next-generation drugs for multiple myeloma.
- To advance the understanding of multiple myeloma biology.
- To facilitate the clinical development of novel therapies.
Main Methods:
- Targeted investments in key research areas.
- Focus on genomics and epigenetics research.
Main Results:
- Elucidation of the basic biology of multiple myeloma.
- Advancement of promising new treatments into clinical development.
Conclusions:
- Genomic and epigenetic research is crucial for advancing multiple myeloma treatment.
- Personalized medicine approaches are key to linking the right treatment to the right patient.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...